Faculty Information

（Last updated : 2022-08-09 11:02:36）

INADA Ken
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Psychiatry

Position

■ Published papers

1.	Original article	The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project. 2022/03/06
2.	Original article	Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study. 2022/03
3.	Original article	Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study. 2022/01/08
4.	Original article	Clinical practice of blonanserin for the treatment of schizophrenia: Advice from Chinese and Japanese experts 2021/09/09
5.	Original article	Development and validation of the Benzodiazepine Hypnotics Withdrawal Symptom Scale (BHWSS) based on item response theory. 2021/06/30
6.	Original article	Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study. 2021/06
7.	Original article	Prevalence of Circadian Rhythm Sleep-Wake Disorder in Outpatients with Schizophrenia and Its Association with Psychopathological Characteristics and Psychosocial Functioning. 2021/04/05
8.	Original article	Current state of hypnotic use disorders: Results of a survey using the Japanese version of Benzodiazepine Dependence Self-Report Questionnaire 2021/03/14
9.	Review article	Unmet needs of patients with major depressive disorder - Findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study. 2020/12/07
10.	Original article	Clinical Factors Associated with New-Onset Glucose Intolerance among Patients with Schizophrenia during Clozapine Treatment:All-Case Surveillance in Japan. 2020/10/13
11.	Original article	Long-Term Efficacy and Safety of Brexpiprazole in Elderly Japanese Patients with Schizophrenia:A Subgroup Analysis of an Open-Label Study 2020/10/06
12.	Original article	Clozapine-induced agranulocytosis in Japan: Changes in leukocyte/neutrophil counts before and after iscontinuation of clozapine 2020/04/22
13.	Case report	Posterior Reversible Encephalopathy Syndrome Due to Acute Water Intoxication in a Patient with Schizophrenia 2020/04/07
14.	Original article	Pharmacological management of depression: Japanese expert consensus 2020/04/01
15.	Other	Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study. 2019/08
16.	Original article	Association between anxious distress in a major depressive episode and bipolarity. 2019/01
17.	Original article	Effectiveness of Pharmacist-convened Multidisciplinary Clinical Team Meetings in Promoting Appropriate Benzodiazepine Receptor Agonist Use 2019
18.	Original article	Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis. 2019
19.	Original article	Escitalopram attenuates fear stress-induced increase in amygdalar dopamine following methamphetamine-induced sensitisation: Implications of fine-tuning action of selective serotonin reuptake inhibitors on emotional processing. 2018/09
20.	Original article	Analysis of Clozapine Use and Safety by Using Comprehensive National Data From the Japanese Clozapine Patient Monitoring Service 2018/08
21.	Original article	Diazepam suppresses the stress-induced dopaminergic release in the amygdala of methamphetamine-sensitized rat 2018/08
22.	Original article	Development of a new benzodiazepine hypnotics withdrawal symptom scale 2018/02
23.	Other	Social cognition and metacognition contribute to accuracy for self-evaluation of real-world functioning in patients with schizophrenia. 2018
24.	Review article	Z-drug for schizophrenia: A systematic review and meta-analysis 2017/10
25.	Case report	Effect of aripiprazole on non-24-hour sleep-wake rhythm disorder comorbid with major depressive disorder 2017/05
26.	Original article	Cognitive insight and functional outcome in schizophrenia; a multi-center orative study with the specific level of functioning scale-Japanese version 2016/08
27.	Original article	Benzodiazepine proper usage in Tokyo womens medical university hospital 2015/08
28.	Original article	Evaluation of the effects of mirtazapine on sleep and appetite in the patient with major depression disorder 2014/11
29.	Original article	Aripiprazole and haloperidol suppress excessive dopamine release in the amygdala in response to conditioned fear stress, but show contrasting effects on basal dopamine release in methamphetamine-sensitized rats 2009
Display 5 items
Display all(29)

■ Academic conference presentation

1.	A Multicenter Study to Evaluate the Usefulness of Pharmacists' Involvement in Psychiatry. 2020/08/21
2.	Anticholinergic drugs prescription for schizophrenia in Japan: Result from EGUIDE project. 2020/08/21
3.	Effect of EGUIDE project on prescription of benzodiazepines with major depressive disorder in NCNP hospital. 2020/08/21
4.	Improvement of psychiatrists' clinical behaviors in accordance with the treatment guidelines for schizophrenia and major depressive disorders using the 'Effegtiveness of Guideline for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project. 2020/08/21
5.	Inmprovemento of the degree of understanding of the toreatment guidlines for schizophenia and major depressive disorder within the Japanese EGUIDE project. 2020/08/21
6.	Prescription patterns in patients with schizophrenia in Japan: first-quality indicator date from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric toreatment(EGUIDE)"project. 2020/08/21
7.	The effect of EGUIDE project on medication for schizophenia. 2020/08/21
8.	The effect of EGUIDE project on treatment for major depressive disorder. 2020/08/21
9.	Unmet need for major depressive disorders: Findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatoric Treatment(EGUIDE)'project. 2020/08/21
10.	Diazepam suppresses the stress-induced dopaminergic release in the amygdala of methamphetamine-sensitized rat 2018/06/19
11.	Escitalopram Attenuates Fear Stress-Induced Increase in Amygdala Dopamine According to Dopaminergic Sensitisation:Implications of Fine-Tuning Action of Selective Serotonin Reuptake Inhibitors on Emotional Processing 2018/06/18
12.	Relationship between withdrawal symptoms of benzodiazepine sleeping pills and background factors 2018/06/18
13.	An open trial of aripiprazole for delirium treatment 2018/06/17
14.	The picture of LAI in Japan 2017/04/27
15.	Benzodiazepine minimaization 2015/06
16.	Mirtazapine treatment can become a preventive measure against the long-term usage of benzodiazepines 2014/06/22
17.	Comparison of Valproate acid and Haloperidol effects on excessive dopamine release in the amygdala in response to conditioned fear stress: Methamphetamine-sensitized rats. 2013/11/10
18.	Evaluation of the effects of Mirtazapine on improving sleep quality and appetite in the patient with major depression disorder 2013/10/24
19.	Differential effect of mood-stabilizer and antipsychotic drugs on excessive dopamine release in the amygdala in response to conditioned fear stress: An in vivo microdialysis study 2013/06/22
20.	study group 4 benzodiazepine dependendence 2012/10/19
21.	The effect of valproic acid on excessive dopamine release in the amygdala in response to conditioned fear stress: An in vivo micro-dialysis study in methamphetamine-sensitized rats 2012/06/06
22.	The effect of the valproic acid on dopamine kinetics in amygdala 2011/12
23.	A prospective study of activation syndrome induced by antidepressants 2011/05
24.	Antipsychotic agents attenuate dopamine fear response in the basolateral amygdala by modulating basal dopamine release; an in vivo microdialysis study 2009/09
Display 5 items
Display all(24)

■ Academic society memberships

1.		The japanese sciety of clinical neuropsychopharmacology
2.	2011/04～	Japanese Society of Neuropsychopharmacology
3.	2006/05～	The japanese Society of Psychiatry and Neurology

■ Academic & professional experience

1.	2009/10～	Lecturer
2.	2005/03～2009/09	Assistant Professor
3.	2003/04～2005/02	Researcher
4.	2001/04～2002/03	Researcher